SMTL ID : 6tpy.1

N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH 1,3-dimethyl-5-(1-((tetrahydro-2H-pyran-4-yl)methyl)-1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-one

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.80 Å

Oligo State

monomer

Ligands

3 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.1: 3 residues within 4Å: Chain A: Q.82, I.85, L.123 3 PLIP interactions: 3 interactions with chain A Water bridges: A:Q.21, A:Q.21, A:A.81 EDO.2: 0 residues within 4Å: (No contacts) No protein-ligand interaction detected (PLIP) EDO.3: 5 residues within 4Å: Chain A: I.59, I.60, K.61, T.62, N.94 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:I.59, A:K.61, A:T.62, A:T.62, A:T.62

1 x NUB: 1,3-dimethyl-5-[1-(oxan-4-ylmethyl)benzimidazol-2-yl]pyridin-2-one(Non-covalent)

NUB.4: 12 residues within 4Å: Chain A: W.40, P.41, F.42, V.46, K.50, L.51, L.53, Y.98, N.99, D.104, I.105, M.108 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:W.40, A:L.51, A:L.51, A:L.53, A:Y.98 Hydrogen bonds: A:N.99 pi-Stacking: A:W.40

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Wellaway, C.R. et al., Discovery of a Bromodomain and Extraterminal Inhibitor with a Low Predicted Human Dose through Synergistic Use of Encoded Library Technology and Fragment Screening. J.Med.Chem. (2020)

Release Date

2020-01-15

Peptides

Bromodomain-containing protein 4: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
AAA

Bromodomain-containing protein 4

Related Entries With Identical Sequence